0
Ernexa Therapeutics Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
0
FY23:
−0.17
FY24:
0.49
FY25:
0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−114
FY22:
−33.2
FY23:
−21.1
FY24:
−15.7
FY25:
−9.32
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
−8.76
(positive)
Change from FY21 to FY25
millions USD
FY21:
−122
FY22:
−24.5
FY23:
−21.7
FY24:
−44.5
FY25:
−14.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
−123
FY22:
−24.6
FY23:
−21.7
FY24:
−44.5
FY25:
−14.1
All amounts in millions USD